SEC Comment Letter for GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416) (GALT) — Jan 19, 2006

GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416)
Date: Jan. 19, 2006 · CIK: 0001133416 · Accession: 0000000000-06-002920

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-31791

Date

January 17, 2006

Author

Jim Atkinson

Form

UPLOAD

Company

GALECTIN THERAPEUTICS INC (GALT) (CIK 0001133416)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 January 17, 2006 Mr. David Platt, Ph.D. Chief Executive Officer Pro-Pharmaceuticals, Inc. 189 Wells Avenue Newton, Massachusetts 02459

Re: Pro-Pharmaceuticals, Inc. Form 10-K for the Fiscal Year Ended December 31, 2004 Filed April 7, 2005 File No. 000-31791

Dear Mr. Platt:

We have completed our review of your Form 10-K and have no further comments at this time.

Sincerely,
Jim Atkinson
Accounting Branch Chief
??

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Via Facsimile and U.S. Mail
Mail Stop 6010

      January 17, 2006

Mr. David Platt, Ph.D.
Chief Executive Officer
Pro-Pharmaceuticals, Inc.
189 Wells Avenue
Newton, Massachusetts 02459

Re:	Pro-Pharmaceuticals, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2004
	Filed April 7, 2005
	File No. 000-31791

Dear Mr. Platt:

      We have completed our review of your Form 10-K and have no
further comments at this time.

								Sincerely,

								Jim Atkinson
								Accounting Branch Chief
??

??

??

??

</TEXT>
</DOCUMENT>

SecProbe.io